Table 1 Demographic characteristics.

From: Comparison of bone mineral loss by combined androgen block agonist versus GnRH in patients with prostate cancer: A 12 month-prospective observational study

Parameter

 

CAB group N = 234

GnRH group N = 70

p-value

Age (mean ± SD, Yr)

  

70.70 ± 7.83

 

72.24 ± 8.63

0.1593§

 (N,%)

50~59

22

9.40

5

7.14

0.1178

 

60~69

69

29.49

20

28.57

 
 

70~79

119

50.85

30

42.86

 
 

≥80

24

10.26

15

21.43

 

BMI (mean ± SD, kg/m2)

 

23.90

±2.91

23.77

±2.91

0.7507§

Past or present smoking history (N,%)

Present smoker

24

10.26

9

12.86

0.2898

 

Ex-smoker

88

37.61

32

45.71

 
 

Never smoker

122

52.14

29

41.43

 

Present smoker (N,%)

 

24

26.69 ± 17.23

9

29.78 ± 14.59

0.6371§

Present non-smoker (N,%)

 

88

25.32 ± 21.67

32

35.41 ± 29.25

0.0714∫

Alcohol consumption (N,%)

 

128

54.70

44

62.86

0.2271

Amount of alcohol consumption (N,%)

≥2units/day*

52

40.63

10

22.73

0.0329

 

<2units/day*

76

59.38

34

77.27

 

Fracture history (N,%)

 

19

8.12

5

7.14

0.7903

Family history of hip fracture (N,%)

 

1

0.43

0

0.00

1.0000‡

Concomitant medication (N,%)

 

96

41.03

38

54.29

0.0499

Osteoporosis-related concurrent disease (N,%)

 

3

1.28

1

1.43

1.0000

initial PSA (mean ± SD, ng/mL)

  

213.46 ± 1287.05

 

30.60 ± 60.15

0.1573

Gleason score (mean ± SD)

  

7.76 ± 1.06

 

7.77 ± 1.20

0.9671§

Prostate volume (mean ± SD, cc)

  

52.09 ± 29.16

 

38.84 ± 16.05

0.0017

Clinical stage at diagnosis

Tx

3

1.28

0

0.00

0.0616

 

T0

1

0.43

0

0.00

 
 

T1

30

12.82

5

7.25

 
 

T2

65

27.78

29

42.03

 
 

T3

103

44.02

32

46.38

 
 

T4

32

13.68

3

4.35

 
 

N0

164

70.09

61

88.41

0.0022

 

N1

70

29.91

8

11.59

 
 

M0

180

76.92

60

86.96

0.0711

 

M1

54

23.08

9

13.04

 

Treatment for prostate cancer

Surgery

92

41.63

34

50.75

 
 

RRP

46

50.00

25

73.53

 
 

LRP

2

2.17

0

0.00

 
 

RALP

36

39.13

7

20.59

 
 

Other

8

8.70

2

5.88

 
 

Radiation

21

9.50

2

2.99

 
 

Primary

18

85.71

1

50.00

 
 

Palliative

3

14.29

1

50.00

 
 

None

116

52.49

32

47.76

 
  1. §Two sample t-test; Wilcoxon’s rank sum test; Pearson’s chi-square test; Fisher’s exact test; Overlapped count; *Alcohol 2 units beer 1 bottle (500 mL), Korean whisky (Soju) 1/4 bottle (90 mL), Korean rice wine 1 bottle (500 mL), Wine 2 glasses (200 mL) or Whisky 2 glasses (60 mL)) RRP: radical retropubic prostatectomy; LRP: laparoscopic radical prostatectomy; RALP: robotic-assisted laparoscopic prostatectomy.